XM does not provide services to residents of the United States of America.
A
A

AXA

News

Mediobanca CEO says conditions not right for cross-border bank M&A in Europe

UPDATE 2-Mediobanca CEO says conditions not right for cross-border bank M&A in Europe Releads with Mediobanca CEO's comments MILAN, Oct 3 (Reuters) - Conditions are not favourable for cross-border banking tie-ups in Europe, the head of Italy's Mediobanca MDBI.MI said on Thursday, adding that a potential acquisition of Commerzbank by UniCredit would not qualify as a cross-border deal.
A
B
C
D
M
U
B
I

AXA To Repurchase Shares For Cancellation For Up To 452.2 Million Euros

BRIEF-AXA To Repurchase Shares For Cancellation For Up To 452.2 Million Euros Oct 2 (Reuters) - AXA SA AXAF.PA : HAS EXECUTED TODAY A SHARE REPURCHASE AGREEMENT WITH AN INVESTMENT SERVICES PROVIDER WILL BUY BACK ITS OWN SHARES FOR CANCELLATION FOR A MAXIMUM AMOUNT OF EURO 452,200,000 SHARE BUYBACK TRANSACTIONS WILL NOT EXTEND BEYOND OCTOBER 30, 202
A

DAE, AXA clinch deal as UK battle over jets 'lost' in Russia kicks off

UPDATE 1-DAE, AXA clinch deal as UK battle over jets 'lost' in Russia kicks off Lessor DAE reaches settlement with Western insurer AXA Aircraft lessors sue over billions of dollars in unpaid claims Five disputes against different insurers rolled into one trial Hundreds of aircraft remain in Russia after Ukraine invasion Trial marks start of one of biggest UK insurance battles Recasts with DAE, AXA settlement By Kirstin Ridley and Sam Tobin LONDON, Oct 2 (Reuters) - Aircraft lessor Dubai Aerospac
A
L
S

Lessor DAE clinches settlement with AXA over jets 'lost' in Russia

Lessor DAE clinches settlement with AXA over jets 'lost' in Russia LONDON, Oct 2 (Reuters) - Aircraft lessor Dubai Aerospace (DAE) has struck a settlement with insurer AXA AXAF.PA over aircraft retained in Russia since the invasion of Ukraine , the London High Court was told on Wednesday. Alistair Schaff, a lawyer for Dubai Aerospace Enterprise, told the first day of a High Court battle between lessors and insurers that a confidential settlement had been secured and DAE's remaining claim now tur
A

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.